.
. MBL deficiency may be also associated with non-infectious diseases, such as lupus erythematosus, rheumatoid arthritis, cystic fibrosis, or common variable immunodeficiency.
The association of MBL-deficiency, IgG-deficiency, vasculitis, Down-syndrome, and a prothrombin mutation has not been reported to occur together in a single patient.
CASE REPORT
The patient is a 30-yo HIV-negative, Caucasian female, with typical features of a Down-syndrome, including epicanthus, long palpebral fissures, low-set ears, saddle nose, brachycephaly, flat face, eversion of the lateral portion of the lower eyelids, arched eyebrows with sparse lateral regions, long eyelashes, small ears, protruding tongue, muscular hypotonia, developmental delay, hyperflexibility of joints, brachydactyly, hypothyroidism, and dermatoglyphic abnormalities 4 . The diagnosis had not been genetically confirmed. Since age 25y she experienced recurrent infections of the lower urinary tract and vulvitis. Cutaneous vasculitis of the lower legs occurred for the first time at age 28y but was definitively diagnosed upon the histological and immunehistological appearance of a skin biopsy not earlier than at age 30y. Since corticosteroids were only partially effective, immunoglobulins were initiated for the first time at age 29y and repeatedly given with success. At age 29y, one month after initiation of an oral contraceptive (levonorgestrel 0.15 mg, ethinylestradiol 0.03 mg), she experienced a deep venous thrombosis of the left lower leg and bilateral, peripheral pulmonary embolism, which required oral anticoagulation with phenprocoumon during one year. Also at age 29y MBL-deficiency and IgG-deficiency were detected during extensive investigation for the cause of recurrent cutaneous vasculitis (Table 1) . At age 30y she developed a local infection of digit one of the left foot after a minimal trauma, for which she received fusidic acid, orally. After two days and intake of 5 tablets she developed a severe, generalized erythrodermia and fever, and required hospitalization. After discontinuation of fusidic acid, and administration of corticosteroids and antihistaminics, the allergenic skin reaction resolved completely. Her history was also noteworthy for recurrent uro-genital infections.
Concerning the laboratory findings, IgG was repeatedly reduced (Table 1 ). There was also a reduction of the subclass IgG2. Antibodies against tetanus were not determined but peneumococcal antibodies were normal. Other immunological parameters, which were normal or negative, include antinuclear antibodies, anti-neutrophil cytoplasmic antibodies (c-ANCA, p-ANCA, atypical ANCA, proteinase-3 ANCA, myeloperoxidase ANCA, lactoferrin ANCA, elastase ANCA, cathepsin G ANCA, BPI-ANCA), cardiolipin IgG, IgM, and IgA, beta2-glycoprotein, circulating immune complexes, ADNase B, CH'50, AH'50, anti-thyroid microsomal antibodies, anti-thyroglobulin antibodies, anti-TPO antibodies, anti-TSH receptor IgG antibodies, phosphatidylserin antibodies, beta2-glycoprotein-I G/A, nRNP antibodies, SM-antibodies, RO/SS-A-antibodies, LA/SS-B antibodies, SCL-70-antibodies, Jo-1-antibodies, histone antibodies, ds-DNA antibodies, ss-DNA antibodies, and prothrombin A antibodies. Lupus anticoagulant was not determined. MBL, however, was markedly decreased (Table 1) . MBL-deficiency was confirmed upon the presence of the MBL-genotype LXA/HYD. Screening for thrombophilia revealed the heterozygous G20210A mutation in the prothrombin gene. Upon assessment of thyroid function hypothyroidism was detected and a therapy with L-thyroxin (0.05 mg/ d) initiated. Radiologic investigations of the lower urinary tract, such as intravenous urography and ultrasound, were normal.
DISCUSSION
The presented patient is interesting for the concurrent occurrence of Down-syndrome, MBL-deficiency, IgGdeficiency, cutaneous vasculitis, and the G20210A prothrombin mutation. Whether these abnormalities were causally related or their common occurrence a mere coincidence remains speculative. A Medline
search did not detect previous reports about the association of Down-syndrome with MBL-deficiency or the G20210A prothrombin-mutation. Repeatedly, however, an association of Down-syndrome with vasculitis has been reported [5] [6] [7] . Rarely, Down-syndrome was also associated with deficiency of IgG subclasses 8, 9 . No reports were detectable when combining "MBL-deficiency" with "G20210A prothrombinmutation", but MBL-deficiency has been reported in association with IgG-deficiency 10, 11 . According to these reports reduction of IgG in MBL-deficiency might be due to binding of IgG to MBL 11 . Rarely, MBL-deficiency has been also reported in association with vasculitis, particularly ANCA-associated small vessel vasculitis 12 and vasculitis in Behcet's disease 13 . The G20210A prothrombin-mutation has not been reported together with IgG deficiency, but repeatedly together with vasculitis, most frequently in Behcet's vasculitis 14 but also together with cutaneous livedoid vasculitis 15 . In single cases IgG deficiency was related to vasculitis 16, 17 . An argument against a common cause of the described abnormalities is that Down syndrome is usually due to trisomy of chromosome 21 and that the genes for MBL, prothrombin, and IgG are located all on chromosomes other than chromosome 21.
Whether the recurrent infections of the uro-genital tract were causally related to MBL-deficiency or IgGdeficiency remains speculative. However, it is well known that both conditions predispose for recurrent infectious disease 8, 18 . Additionally, the recurrent infections could be due to urinary tract abnormalities, frequently found in Down-syndrome 19 . However, in our patient no urinary tract abnormality has been found on cystoscopy or imaging of the lower or upper urinary tract. Possibly, urinary tract infections were due to colonization of the urinary tract by fungi, a complication of recurrent antibiotic therapy. They could be also attributed to corticosteroid therapy but an argument against this is that uro-genital tract infections occurred already long before the initiation of corticosteroids. Low IgG was interpreted as IgGdeficiency since also subclass IgG2 was reduced. Low IgG due to MBL-deficiency was excluded, since such a causal relation has rarely been reported and since also subclass IgG2 was reduced. Though vasculitis was also rarely related to MBL-deficiency 12, 13 or IgGdeficiency 16, 17 , it cannot be definitively excluded that immunodeficiency contributed to the development of the dermal abnormalities, since cutaneous vasculitis has been previously reported in a patient with Down syndrome 5 and since patients carrying MBL-haplotypes are at risk of developing systemic lupus erythemtosus 20 . Whether deep venous thrombosis and pulmonary embolism were due to the prothrombin mutation or the oral contraceptives, or both, remains speculative. To reduce the risk of recurrent thromboembolism the patient was recommended to withdraw oral contraceptives but no oral anticoagulation was initiated. This case shows that Down-syndrome, MBLdeficiency, IgG-deficiency, recurrent uro-genital infections, vasculitis and the prothrombin mutation may concur in the same patient. Recurrent infections and vasculitis may be attributable to immunodeficiency from low IgG or low MBL.
